Ibrahim B. Dagher - Jan 1, 2025 Form 4 Insider Report for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Signature
/s/ Ibrahim B. Dagher
Stock symbol
BCLI
Transactions as of
Jan 1, 2025
Transactions value $
$0
Form type
4
Date filed
1/7/2025, 04:11 PM
Previous filing
Jul 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCLI Common Stock Award $0 +50K +296.75% $0.00 66.8K Jan 1, 2025 Direct F1
holding BCLI Common Stock 10.7K Jan 1, 2025 By the Reporting Person's Roth IRA F2
holding BCLI Common Stock 2K Jan 1, 2025 See Note F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of restricted stock awarded under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
F2 Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024.
F3 Represents shares held in a custodial account under the Uniform Transfers to Minors Act for the benefit of the Reporting Person's child. The Reporting Person is the custodian of such account. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.